Results 111 to 120 of about 10,915 (160)

[Comparison of psychological distress and quality of life in patients with advanced liver cancer before and after transformation therapy]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Pan L, Zhang W, Hu B, Li J, Feng Y, Deng F, Yang L, Zhou J, Ma W, Jiang C, Xu Y, Lu S.   +11 more
europepmc   +1 more source

原发性肝癌术后复发的再次外科治疗

Zhongshan Daxue xuebao. Yixue kexue ban, 1992
1980～1990年,作者收治原发性肝癌660例,手术切除124例(18.8％)。术后肝内复发者32例(肝内复发率25.8％),2 年以内复发者占93.8％。93.7％合并肝硬化,15.5％并发门脉高压症。复发肝癌中4例(3.2％,4/124)行再切除,术后生存平均26.8月;22例行B超引导肝癌复发灶无水酒精注射术,术后8例死亡,平均生存8.5月;10例行肝动脉栓塞化疗或肝动脉结扎及插管化疗,术后生存平均16.8月,对照组仅4.5月。复发癌再次外科治疗以再切除术为首选(术后生存26.8～42.6月 ...
doaj  

[HDAC2-mediated H3K27 acetylation promotes the proliferation and migration of hepatocellular carcinoma cells]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Tang S, Yang B, Li J, Zhao L, Wang Y, Wang S.   +5 more
europepmc   +1 more source

[NDRG2 inhibits tumorigenesis of hepatocellular carcinoma by regulating metabolism of phospholipids and triglyceride: a metabonomic analysis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Wang J, Yuan Y, Zhang K, Sun X, Bu X, Dong J, Wu Y, Tian H, Shen L.   +8 more
europepmc   +1 more source

[SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zou J, Wang H, Zhang D.
europepmc   +1 more source

[Mechanism of miRNA-3679 Inhibiting Downstream ZADH2-Target Genes to Promote Hepatocellular Carcinoma Cell Proliferation]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban, 2022
He JY, Zhou XQ, Wang WT.
europepmc   +1 more source

C型肝炎ウイルス感染者における飲酒習慣は肝細胞癌のリスクを上昇させるか? [PDF]

博士(医学 ...
福島, 若葉
core  

[Angio-associated migratory cell protein is highly expressed in hepatocellular carcinoma and promotes tumor cell invasion and metastasis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li C, Yin G, Cheng X, Jiang Y.
europepmc   +1 more source

[Construction and verification of a prognostic model combining anoikis and immune prognostic signatures for primary liver cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Y, Li J, Wang Y, Hua M, Hu W, Zhang X.   +5 more
europepmc   +1 more source

[P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Shang L, Jiang W, Zhang J, Wu W.
europepmc   +1 more source